Skip to main content
Erschienen in: Virchows Archiv 3/2006

01.09.2006 | Original Article

Tissue shrinkage after fixation with formalin injection of prostatectomy specimens

verfasst von: Sara Jonmarker, Alexander Valdman, Anna Lindberg, Magnus Hellström, Lars Egevad

Erschienen in: Virchows Archiv | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Prostate cancer volume correlates with stage, grade, and progression after prostatectomy. When tumor volume is measured planimetrically, results are multiplied by a correction factor to compensate for tissue shrinkage caused by processing. Injection of formalin into prostatectomy specimens was suggested for improved fixation. Our aim was to investigate how this affects the prostate volume. We studied 142 radical prostatectomy specimens. All prostates were immersed in 10% formalin. In 84 prostates (59%) we also injected 20 ml of formalin before routine fixation. The prostates were weighed unfixed after injection and after final fixation. The specimens were sliced and totally embedded. The transverse diameters of the prostates were measured on unfixed specimens and microscopic sections. The average weight loss after final fixation was 5.8 and 8.6% for formalin-injected specimens and standard-fixed specimens, respectively (p<0.001). However, when total shrinkage was estimated from the transverse diameters, there was no difference related to fixation technique (p=0.59). The average linear shrinkage was 4.5%, corresponding to a volume correction factor of 1.15. We conclude that formalin injection for fixation of prostate tissue does not influence tumor volume calculation compared to conventional fixation.
Literatur
1.
Zurück zum Zitat Blackwell KL, Bostwick DG, Myers RP, Zincke H, Oesterling JE (1994) Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. J Urol 151:1565–1570PubMed Blackwell KL, Bostwick DG, Myers RP, Zincke H, Oesterling JE (1994) Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. J Urol 151:1565–1570PubMed
2.
Zurück zum Zitat Boswick DG, Graham SDJ, Napalkov P, Abrahamsson PA, di Sant’agnese PA, Algaba F, Hoisaeter PA, Lee F, Littrup P, Mostofi FK, Denis L, Schroeder F, Murphy GP (1993) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41:403CrossRef Boswick DG, Graham SDJ, Napalkov P, Abrahamsson PA, di Sant’agnese PA, Algaba F, Hoisaeter PA, Lee F, Littrup P, Mostofi FK, Denis L, Schroeder F, Murphy GP (1993) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41:403CrossRef
3.
Zurück zum Zitat Cupp MR, Bostwick DG, Myers RP, Oesterling JE (1995) The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 153:1543–1548PubMedCrossRef Cupp MR, Bostwick DG, Myers RP, Oesterling JE (1995) The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 153:1543–1548PubMedCrossRef
4.
Zurück zum Zitat De Marzo AM, Fedor H, Gage WR, Rubin MA (2002) Inadequate formalin fixation decreases reliability of p27Kip1 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays. Human Pathol 33:756–760CrossRef De Marzo AM, Fedor H, Gage WR, Rubin MA (2002) Inadequate formalin fixation decreases reliability of p27Kip1 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays. Human Pathol 33:756–760CrossRef
5.
Zurück zum Zitat DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI (2003) Pathological and molecular aspects of prostate cancer. Lancet 361:955–964PubMedCrossRef DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI (2003) Pathological and molecular aspects of prostate cancer. Lancet 361:955–964PubMedCrossRef
6.
Zurück zum Zitat Epstein JI, Oesterling JE, Walsh PC (1988) Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer. J Urol 139:980–984PubMed Epstein JI, Oesterling JE, Walsh PC (1988) Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer. J Urol 139:980–984PubMed
7.
Zurück zum Zitat Epstein JI, Carmichael M, Partin AW, Walsh PC (1993) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow up. J Urol 149:1478–1481PubMed Epstein JI, Carmichael M, Partin AW, Walsh PC (1993) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow up. J Urol 149:1478–1481PubMed
8.
Zurück zum Zitat Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368–374PubMedCrossRef Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368–374PubMedCrossRef
9.
Zurück zum Zitat Greene DR, Egawa S, Neerhut G, Flanagan W, Wheeler TM, Scardino PT (1991) The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. J Urol 145:324–329PubMed Greene DR, Egawa S, Neerhut G, Flanagan W, Wheeler TM, Scardino PT (1991) The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. J Urol 145:324–329PubMed
10.
Zurück zum Zitat Häggarth L, Busch C, Norberg M, Häggman M, Norlen BJ, Egevad L (2005) Prediction of the volume of large prostate cancers by multiple core biopsies. Scand J Urol Nephrol 39:380–386PubMedCrossRef Häggarth L, Busch C, Norberg M, Häggman M, Norlen BJ, Egevad L (2005) Prediction of the volume of large prostate cancers by multiple core biopsies. Scand J Urol Nephrol 39:380–386PubMedCrossRef
11.
Zurück zum Zitat Häggman M, Nybacka O, Nordin B, Busch C (1994) Standardized in vitro mapping with multiple core biopsies of total prostatectomy specimens: localization and prediction of tumour volume and grade. Br J Urol 74:617–625PubMedCrossRef Häggman M, Nybacka O, Nordin B, Busch C (1994) Standardized in vitro mapping with multiple core biopsies of total prostatectomy specimens: localization and prediction of tumour volume and grade. Br J Urol 74:617–625PubMedCrossRef
12.
Zurück zum Zitat Hoedemaeker RF, Ruijter ET, Ruizeveld-de Winter JA, van der Kaa CA, the Biomed II MPC Study Group, van der Kwast TH (1998) Processing radical prostatectomy specimens. J Urol Pathol 9:211–222CrossRef Hoedemaeker RF, Ruijter ET, Ruizeveld-de Winter JA, van der Kaa CA, the Biomed II MPC Study Group, van der Kwast TH (1998) Processing radical prostatectomy specimens. J Urol Pathol 9:211–222CrossRef
13.
Zurück zum Zitat Humphrey PA (1993) Complete histologic serial sectioning of a prostate gland with adenocarcinoma. Am J Surg Pathol 17:468–472PubMedCrossRef Humphrey PA (1993) Complete histologic serial sectioning of a prostate gland with adenocarcinoma. Am J Surg Pathol 17:468–472PubMedCrossRef
14.
Zurück zum Zitat Humphrey PA, Walther PJ, Currin SM, Vollmer RT (1991) Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison. Am J Surg Pathol 15:1165–1170PubMed Humphrey PA, Walther PJ, Currin SM, Vollmer RT (1991) Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison. Am J Surg Pathol 15:1165–1170PubMed
15.
Zurück zum Zitat Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M (2004) Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 172:508–511PubMedCrossRef Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M (2004) Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 172:508–511PubMedCrossRef
16.
Zurück zum Zitat Lerner SE, Blute ML, Zincke H (1996) Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Semin Urol Oncol 14:12–20; discussion 21PubMed Lerner SE, Blute ML, Zincke H (1996) Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Semin Urol Oncol 14:12–20; discussion 21PubMed
17.
Zurück zum Zitat McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 23:258–266PubMedCrossRef McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 23:258–266PubMedCrossRef
19.
Zurück zum Zitat McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA (1986) Patterns of progression in prostate cancer. Lancet 1:60–63PubMedCrossRef McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA (1986) Patterns of progression in prostate cancer. Lancet 1:60–63PubMedCrossRef
20.
Zurück zum Zitat Miller GJ (1989) Histopathology of prostate cancer: prediction of malignant behavior and correlation with ultrasonography. Urology 33:18–26PubMedCrossRef Miller GJ (1989) Histopathology of prostate cancer: prediction of malignant behavior and correlation with ultrasonography. Urology 33:18–26PubMedCrossRef
21.
Zurück zum Zitat Noguchi M, Stamey TA, McNeal JE, Yemoto CE (2000) Assessment of morphometric measurements of prostate carcinoma volume. Cancer 89:1056–1064PubMedCrossRef Noguchi M, Stamey TA, McNeal JE, Yemoto CE (2000) Assessment of morphometric measurements of prostate carcinoma volume. Cancer 89:1056–1064PubMedCrossRef
22.
Zurück zum Zitat Norberg M, Holmberg L, Wheeler T, Magnusson A (1994) Five year follow-up after radical prostatectomy for localized prostate cancer-a study of the impact of different tumor variables on progression. Scand J Urol Nephrol 28:391–399PubMedCrossRef Norberg M, Holmberg L, Wheeler T, Magnusson A (1994) Five year follow-up after radical prostatectomy for localized prostate cancer-a study of the impact of different tumor variables on progression. Scand J Urol Nephrol 28:391–399PubMedCrossRef
23.
Zurück zum Zitat Partin AW, Epstein JI, Cho KR, Gittlesohn AM, Walsh PC (1989) Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141:341–345PubMed Partin AW, Epstein JI, Cho KR, Gittlesohn AM, Walsh PC (1989) Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141:341–345PubMed
24.
Zurück zum Zitat Schmid H-P, McNeal JE (1992) An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16:184–191PubMed Schmid H-P, McNeal JE (1992) An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16:184–191PubMed
25.
Zurück zum Zitat Schned AR, Wheeler KJ, Hodorowski K, Heaney JA, Ernstoff MS, Amdur RJ, Harris RD (1996) Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 20:1501–1506PubMedCrossRef Schned AR, Wheeler KJ, Hodorowski K, Heaney JA, Ernstoff MS, Amdur RJ, Harris RD (1996) Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 20:1501–1506PubMedCrossRef
26.
Zurück zum Zitat Stamey TA, McNeal JE, Freiha FS, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139:1235–1241PubMed Stamey TA, McNeal JE, Freiha FS, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139:1235–1241PubMed
27.
Zurück zum Zitat Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 281:1395–1400PubMedCrossRef Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 281:1395–1400PubMedCrossRef
Metadaten
Titel
Tissue shrinkage after fixation with formalin injection of prostatectomy specimens
verfasst von
Sara Jonmarker
Alexander Valdman
Anna Lindberg
Magnus Hellström
Lars Egevad
Publikationsdatum
01.09.2006
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 3/2006
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-006-0259-5

Weitere Artikel der Ausgabe 3/2006

Virchows Archiv 3/2006 Zur Ausgabe

Neu im Fachgebiet Pathologie